Ms. Hart worked alongside New Jersey’s biopharmaceutical industry leaders to establish BioNJ in 1994. Dedicated to BioNJ’s mission to help our Members help Patients, Ms. Hart is recognized as a respected thought leader and influential advocate. Under Ms. Hart’s leadership, BioNJ has become the trusted voice of the life sciences industry in New Jersey – working directly with legislative leaders in both Trenton and Washington D.C. to advance the life sciences industry, foster medical innovation and patient access while ensuring health equity and healthcare affordability. Most recently, she was named by Governor Murphy as the Chair of the New Jersey Commission on Science, Innovation and Technology.
With the onset of COVID-19, Ms. Hart was named by Governor Murphy to New Jersey’s Restart and Recovery Advisory Council and by Assembly Speaker Craig Coughlin to the Economic Advisory Council to Restart the Economy, created to advise State leadership on economic matters impacted by COVID-19.
Additionally, Ms. Hart is the Co-Chair of the New Jersey Commission on Higher Education Strategic Plan Working Group on Research, Innovation and the Talent and the New Jersey Commission on Higher Education and Business Partnership. She also served as Chair of the bipartisan, bicameral New Jersey Biotechnology Task Force which was charged with making recommendations to the Legislature for fostering the growth of the biotechnology industry in New Jersey most of which have been enacted.
Ms. Hart is Co-Chair of We Work for Health New Jersey, serves on the boards of the New Jersey Chamber of Commerce and Choose New Jersey, the New Jersey Equity in Commercialization Collective Advisory Board and the New Jersey Innovation Institute. She chaired the EDA’s Commercialization Center for Innovative Technologies (CCIT) Board and served as a member of the New Jersey Economic Development Authority’s (EDA) Technology Advisory Board.
A strong advocate for advancing education, Ms. Hart sits on the Board of the Blanche and Irwin Lerner Center for the Study of Pharmaceutical Management at Rutgers University Business School. She served on the Advisory Boards for Students 2 Science, the New Jersey Institute of Technology’s (NJIT) Biomedical Engineering Program, and the founding Advisory Board that guided the establishment of the nationally recognized Monmouth County Biotechnology High School.
A respected opinion leader, Ms. Hart has testified before State and federal legislative committees, authored numerous op-eds and is a frequent speaker on issues impacting medical innovation and Patient access.
Ms. Hart was named one of the world’s 100 Most Influential People in Biotechnology by Scientific American Worldview; a PharmaVOICE 2021 Red Jacket Honoree and to PharmaVOICE‘s 100 Most Inspiring People list with repeat appearances on ROI-NJ’s Influencers Power List; ROI-NJ’s Healthcare Influencers; ROI-NJ’s Women in Business List; NJBIZ’s Manufacturing 50; as well as #5 NJBIZ’s Most Influential Healthcare Leaders list; one of New Jersey’s top CEOs by COMMERCE Magazine and for the 11th time in 2023 to the NJBIZ Power 100, a listing of the 100 most influential people in New Jersey business.
Ms. Hart holds an M.S. from the S. I. Newhouse School at Syracuse University where she graduated cum laude and a B.A. from Trenton State College, now The College of New Jersey, where she graduated magna cum laude.
With the onset of COVID-19, Ms. Hart was named by Governor Murphy to New Jersey’s Restart and Recovery Advisory Council and by Assembly Speaker Craig Coughlin to the Economic Advisory Council to Restart the Economy, created to advise State leadership on economic matters impacted by COVID-19.
Additionally, Ms. Hart is the Co-Chair of the New Jersey Commission on Higher Education Strategic Plan Working Group on Research, Innovation and the Talent and the New Jersey Commission on Higher Education and Business Partnership. She also served as Chair of the bipartisan, bicameral New Jersey Biotechnology Task Force which was charged with making recommendations to the Legislature for fostering the growth of the biotechnology industry in New Jersey most of which have been enacted.
Ms. Hart is Co-Chair of We Work for Health New Jersey, serves on the boards of the New Jersey Chamber of Commerce and Choose New Jersey, the New Jersey Equity in Commercialization Collective Advisory Board and the New Jersey Innovation Institute. She chaired the EDA’s Commercialization Center for Innovative Technologies (CCIT) Board and served as a member of the New Jersey Economic Development Authority’s (EDA) Technology Advisory Board.
A strong advocate for advancing education, Ms. Hart sits on the Board of the Blanche and Irwin Lerner Center for the Study of Pharmaceutical Management at Rutgers University Business School. She served on the Advisory Boards for Students 2 Science, the New Jersey Institute of Technology’s (NJIT) Biomedical Engineering Program, and the founding Advisory Board that guided the establishment of the nationally recognized Monmouth County Biotechnology High School.
A respected opinion leader, Ms. Hart has testified before State and federal legislative committees, authored numerous op-eds and is a frequent speaker on issues impacting medical innovation and Patient access.
Ms. Hart was named one of the world’s 100 Most Influential People in Biotechnology by Scientific American Worldview; a PharmaVOICE 2021 Red Jacket Honoree and to PharmaVOICE‘s 100 Most Inspiring People list with repeat appearances on ROI-NJ’s Influencers Power List; ROI-NJ’s Healthcare Influencers; ROI-NJ’s Women in Business List; NJBIZ’s Manufacturing 50; as well as #5 NJBIZ’s Most Influential Healthcare Leaders list; one of New Jersey’s top CEOs by COMMERCE Magazine and for the 11th time in 2023 to the NJBIZ Power 100, a listing of the 100 most influential people in New Jersey business.
Ms. Hart holds an M.S. from the S. I. Newhouse School at Syracuse University where she graduated cum laude and a B.A. from Trenton State College, now The College of New Jersey, where she graduated magna cum laude.
Speaking In
11:00 AM - 12:15 PM
Wednesday, June 7
